アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
A synthetic peptide corresponding to residues in the C-term of human Adducin was used as immunogen.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab40760 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/5000 - 1/50000. Detects a band of approximately 120 kDa (predicted molecular weight: 120 kDa).|
|IHC-P||1/250 - 1/500.|
|ICC/IF||1/250 - 1/500.|
ab40760 has not yet been referenced specifically in any publications.